OBJECTIVE To evaluate the impact of components of metabolic syndrome (MetS) on urinary outcomes after surgery for severe lower urinary tract symptoms (LUTS) due to benign prostatic enlargement (BPE), as central obesity can be associated with the development of BPE and with the worsening of LUTS. PATIENTS AND METHODS A multicentre prospective study was conducted including 378 consecutive men s...

BACKGROUND There is still controversy as to whether initial combination treatment is superior to serial addition of anticholinergics after maintenance or induction of alpha blockers in benign prostatic hyperplasia (BPH)/lower urinary tract symptoms (LUTS). OBJECTIVE The objective of this study was to determine the benefits and safety of initial combination treatment of an alpha blocker with a...

The majority of patients with multiple sclerosis (MS) develop troublesome lower urinary tract symptoms (LUTS). Anecdotal reports suggest that cannabis may alleviate LUTS, and cannabinoid receptors in the bladder and nervous system are potential pharmacological targets. In an open trial we evaluated the safety, tolerability, dose range, and efficacy of two whole-plant extracts of Cannabis sativa...

Background Lower urinary tract symptoms (LUTS) are commonly experienced among ageing males. The increasing prevalence of late-onset hypogonadism suggests a possible relationship between serum testosterone and severity LUTS. This study examines the association lower Malaysian men, as reflected by International Prostate Symptom Score (IPSS). Method A total 163 men with LUTS were enrolled in cross...

Lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) are highly prevalent in older men. The storage subcategory of LUTS is synonymous with overactive bladder syndrome (OAB) which is an empirical diagnosis. Traditionally, alpha-blockers are widely prescribed to manage LUTS of BPH, although storage symptoms may persist in many men despite treatment. Therefore, since therapie...

Lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) are highly prevalent in older men. The storage subcategory of LUTS is synonymous with overactive bladder (OAB) syndrome, which is an empirical diagnosis. Traditionally, alpha-blockers are widely prescribed to manage the LUTS of BPH, although storage symptoms may persist in many men despite treatment. Therefore, because t...

Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) are highly prevalent in older men. The long-term clinical utility of lifestyle modification and oral medications for LUTS is limited. There a great need safe, effective, durable BPH therapies men who unsuccessfully attempt conservative measures. Enthusiasm transurethral resection the prostate has declined due su...

AIMS The aim of this article is to provide insight to clinicians who principally treat adults, about non-neurogenic lower urinary tract symptoms (LUTS) either pre-dating or presenting in adolescence. Assessment fundamentals, diagnostic classification, and rationale behind the process of care are discussed. METHODS Standardized terms are used to describe the current classification of symptoms ...

We aimed to provide guidelines for the evidence-based diagnosis and treatment of benign prostatic hyperplasia (BPH) and basic information about diagnostic testing, drug therapy, and surgical treatment. The target population in which to apply the guideline is men over 40 years of age who complain of lower urinary tract symptoms (LUTS). The intended users of this guideline are all physicians who ...

Systematic review of the diagnostic performance of non-invasive tests in diagnosing bladder outlet obstruction or detrusor underactivity in men with lower urinary tract symptoms European Association of Urology Male LUTS Guidelines Panel Stavros Gravas, Thorsten Bach, Alexander Bachmann, Marcus J Drake, Mauro Gacci, Christian Gratzke, Stephan Madersbacher, Charalambos Mamoulakis, Kari AO Tikkine...